首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   6213篇
  免费   467篇
  国内免费   20篇
耳鼻咽喉   43篇
儿科学   219篇
妇产科学   229篇
基础医学   917篇
口腔科学   113篇
临床医学   875篇
内科学   1153篇
皮肤病学   132篇
神经病学   520篇
特种医学   124篇
外科学   483篇
综合类   64篇
一般理论   22篇
预防医学   734篇
眼科学   145篇
药学   411篇
中国医学   5篇
肿瘤学   511篇
  2023年   68篇
  2022年   32篇
  2021年   138篇
  2020年   156篇
  2019年   174篇
  2018年   183篇
  2017年   166篇
  2016年   146篇
  2015年   182篇
  2014年   287篇
  2013年   386篇
  2012年   510篇
  2011年   507篇
  2010年   273篇
  2009年   255篇
  2008年   438篇
  2007年   458篇
  2006年   411篇
  2005年   399篇
  2004年   372篇
  2003年   314篇
  2002年   290篇
  2001年   33篇
  2000年   21篇
  1999年   33篇
  1998年   46篇
  1997年   40篇
  1996年   29篇
  1995年   29篇
  1994年   33篇
  1993年   31篇
  1992年   18篇
  1991年   10篇
  1990年   9篇
  1989年   7篇
  1988年   11篇
  1987年   8篇
  1985年   9篇
  1984年   11篇
  1983年   17篇
  1982年   20篇
  1981年   15篇
  1980年   17篇
  1979年   8篇
  1978年   12篇
  1977年   12篇
  1976年   9篇
  1974年   11篇
  1973年   11篇
  1972年   8篇
排序方式: 共有6700条查询结果,搜索用时 0 毫秒
1.
2.
3.
4.

Background

We have recently shown that human epididymis protein 4 (HE4) levels correlate with the severity of cystic fibrosis (CF) lung disease. However, there are no data on how HE4 levels alter in patients receiving CFTR modulating therapy.

Methods

In this retrospective clinical study, 3 independent CF patient cohorts (US-American: 29, Australian: 12 and Irish: 19 cases) were enrolled carrying at least one Class III CFTR CF-causing mutation (p.Gly551Asp) and being treated with CFTR potentiator ivacaftor. Plasma HE4 was measured by immunoassay before treatment (baseline) and 1–6?months after commencement of ivacaftor, and were correlated with FEV1 (% predicted), sweat chloride, C-reactive protein (CRP) and body mass index (BMI).

Results

After 1?month of therapy, HE4 levels were significantly lower than at baseline and remained decreased up to 6?months. A significant inverse correlation between absolute and delta values of HE4 and FEV1 (r?=??0.5376; P?<?.001 and r?=??0.3285; P?<?.001), was retrospectively observed in pooled groups, including an independent association of HE4 with FEV1 by multiple regression analysis (β?=??0.57, P?=?.019). Substantial area under the receiver operating characteristic curve (ROC-AUC) value was determined for HE4 when 7% mean change of FEV1 (0.722 [95% CI 0.581–0.863]; P?=?.029) were used as classifier, especially in the first 2?months of treatment (0.806 [95% CI 0.665–0.947]; P?<?.001).

Conclusions

This study shows that plasma HE4 levels inversely correlate with lung function improvement in CF patients receiving ivacaftor. Overall, this potential biomarker may be of value for routine clinical and laboratory follow-up of CFTR modulating therapy.  相似文献   
5.

Purpose

To investigate the current state of gender diversity among invited coordinators at the Society of Interventional Radiology (SIR) Annual Scientific Meeting and to compare the academic productivity of female interventional radiologists to that of invited male coordinators.

Materials and Methods

Faculty rosters for the SIR Annual Scientific Meetings from 2015 to 2017 were stratified by gender to quantify female representation among those asked to lead and coordinate podium sessions. To quantify academic productivity and merit, H-index, publications, and authorship by females over a 6-year period (2012–2017) were statistically compared to that of recurring male faculty.

Results

From 2015 to 2017, women held 7.1% (9/126), 4.3%, (8/188), and 13.7% (27/197) of the available coordinator positions for podium sessions, with no representation at the plenary sessions, and subject matter expertise was concentrated in economics and education. Academic productivity of the top quartile of published female interventional radiologists was statistically similar to that of the invited male faculty (H-index P = .722; total publications P = .689; and authorship P = .662).

Conclusions

This study found that senior men dominate the SIR Annual Scientific Meeting, with few women leading or coordinating the podium sessions, despite their established academic track record.  相似文献   
6.
7.
8.
9.
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号